ArticleCarcinogenesis2022

Fenretinide combines perturbation of signaling kinases, cell-extracellular matrix interactions and matrix metalloproteinase activation to inhibit invasion in oral squamous cell carcinoma cells.

Daren Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.